I just posted about this article elsewhere, with the Lyme (borrelia) angle having caught my attention...
"F.D.A. Moves to Regulate Lab-Developed Tests"
"...The decision, long in coming, has been fiercely opposed by some laboratories and pathologists, who say that regulation by the agency is unnecessary and would significantly increase the cost and time needed to develop tests, stifling innovation and depriving patients of some vital tools...
Test systems or kits that are sold to hospitals, laboratories, doctor’s offices and the public have long been regulated as medical devices, giving the agency the opportunity to review them before they are marketed. But tests developed and performed by a single laboratory, with all samples being sent to that laboratory, have typically not been. The F.D.A. had claimed the legal authority to regulate these so-called laboratory-developed tests, but said it was exercising “enforcement discretion” not to do so.
The agency said Thursday that the discretion must now end because circumstances had changed...
The F.D.A. first proposed regulating certain lab-developed tests in 2006. It held two days of public hearings on the issue in 2010.
But its efforts so far have run into fierce opposition. The agency’s draft guidance on how it would regulate these tests has apparently been locked up, ostensibly under review, by the White House Office of Management and Budget.
Five Democratic senators who favor F.D.A. regulation, led by Edward J. Markey of Massachusetts, wrote to the budget office on July 2, demanding that it release the draft guidance...
But with some Republican opposition to such regulation, Congress enacted a requirement that it be notified 60 days in advance of the publication of the draft guidance. Presumably this would allow time for efforts to stop publication.
The F.D.A. fulfilled that obligation on Thursday, notifying Congress that the draft guidance would be published in 60 days, after which it would be
open for public comment. In so doing, the agency provided a preview of what the guidance would say.
Those who support the agency’s move to oversee lab-developed tests say such tests can play pivotal roles in determining whether someone is ill or what treatment to provide, so an errant result can be harmful. The Centers for Disease Control and Prevention, for instance, recently warned about false readings from a laboratory-developed test for Lyme disease.
But laboratories, pathologists and some testing companies say the need to obtain F.D.A. approval would stifle innovation...
The labs also dispute that the agency even has jurisdiction. They say that testing is a service, not a medical device. It is unclear yet whether certain laboratory trade groups might now go to court seeking a ruling that the agency has no jurisdiction over lab-developed tests...
FULL ARTICLE:
http://www.nytimes.com/2014/08/01/business/fda-to-regulate-lab-developed-test-kits.html